Serum carnosinase activities in central nervous system disorders.

[1]  L. Mosovich,et al.  Serum Carnosinase Deficiency Concomitant with Mental Retardation , 1973, Pediatric Research.

[2]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[3]  M. Swash,et al.  Motor neuron disease. , 1992, Postgraduate medical journal.

[4]  J. Berstad,et al.  HOMOCARNOSINOSIS. 2. A FAMILIAL METABOLIC DISORDER ASSOCIATED WITH SPASTIC PARAPLEGIA, PROGRESSIVE MENTAL DEFICIENCY, and RETINAL PIGMENTATION , 1976, Acta neurologica Scandinavica.

[5]  S. Kish,et al.  HOMOCARNOSINOSIS: INCREASED CONTENT OF HOMOCARNOSINE AND DEFICIENCY OF HOMOCARNOSINASE IN BRAIN , 1979, Journal of neurochemistry.

[6]  J. Lenney,et al.  Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[7]  P. Duane,et al.  The Relationship between Serum Carnosinase Activity and Severity of Liver Failure in Patients with Alcoholic and Primary Biliary Cirrhosis , 1991 .

[8]  F. Margolis Carnosine in the Primary Olfactory Pathway , 1974, Science.

[9]  K. Miyai,et al.  Fluorometric Assay of Human Serum Carnosinase Activity in Normal Children, Adults and Patients with Myopathy , 1984, Annals of clinical biochemistry.

[10]  L. Gjessing,et al.  HOMOCARNOSINOSIS: A NEW METABOLIC DISORDER ASSOCIATED WITH SPASTICITY AND MENTAL RETARDATION , 1974 .

[11]  M. Jackson,et al.  Homocarnosinosis patients and great apes have a serum protein that cross-reacts with human serum carnosinase. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[12]  M. Jackson,et al.  Purification and properties of human serum carnosinase. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[13]  V. Preedy,et al.  Clinical Studies of the Post-Viral Fatigue Syndrome (PVFS) with Special Reference to Skeletal Muscle Function , 1988 .

[14]  S. Kish,et al.  REGIONAL DISTRIBUTION OF HOMOCARNOSINE, HOMOCARNOSINE‐CARNOSINE SYNTHETASE AND HOMOCARNOSINASE IN HUMAN BRAIN , 1979, Journal of neurochemistry.

[15]  J. Aldstadt,et al.  Effects of carnosine and anserine on muscle and non-muscle phosphorylases. , 1984, Comparative biochemistry and physiology. B, Comparative biochemistry.

[16]  T. Peters,et al.  Serum carnosinase activities in patients with alcoholic chronic skeletal muscle myopathy. , 1988, Clinical science.

[17]  P. W. Chan,et al.  Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[18]  V. Preedy,et al.  The relationship between muscle fibre atrophy factor, plasma carnosinase activities and muscle RNA and protein composition in chronic alcoholic myopathy. , 1993, Alcohol and alcoholism.

[19]  T. Perry,et al.  Carnosinemia. A new metabolic disorder associated with neurologic disease and mental defect. , 1967, The New England journal of medicine.

[20]  H. Schlüter,et al.  Effect of plasma from patients with essential hypertension on vascular resistance in the isolated perfused rat kidney. , 1991, Clinical science.